Medical scientific publisher informa Healthcare, US, has announced plans to publish this week a complete bench-to-bedside guide to cancer vaccines in development. Cancer Vaccines: Challenges and Opportunities in Translation is informa's latest addition to its translational medicine series.
The guide traces gaps, challenges and difficulties encountered in the past, including hurdles associated with the translation of immunology research into clinical opportunities, while outlining potential solutions and strategies for success. It covers topics relevant to industry, translation and development - with an eye on science as well as improving patient care.
The book adapts all the latest scientific discoveries pertaining to the development and optimisation process of cancer vaccines to clinical practice. This is projected to make it a valuable resource for scientists, researchers and clinicians worldwide. Other titles in the series include Diabetes: Translating Research into Practice, 2008 Cancer Supportive Care: Advances in Therapeutic Strategies, 2008 Cancer Vaccines: Challenges and Opportunities in Translation, 2008 Melanoma: Translational Research and Emerging Therapies, 2008 Breast Cancer: Translational Therapeutic Strategies, 2007 Lung Cancer: Translational and Emerging Therapies, and 2007 Multiple Myeloma: Translational and Emerging Therapies.
The book, authored by Dr. Adrian Bot and Dr. Mihail Obrocea, is available from wholesalers, online retailers, book stores, as well as directly from informa through www.crcpress.com.
